SEBASTIANI, MARCO
 Distribuzione geografica
Continente #
AS - Asia 8.048
NA - Nord America 3.690
SA - Sud America 1.916
EU - Europa 1.697
AF - Africa 571
OC - Oceania 7
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.933
Nazione #
SG - Singapore 4.131
US - Stati Uniti d'America 3.498
BR - Brasile 1.424
VN - Vietnam 1.310
CN - Cina 855
HK - Hong Kong 830
IT - Italia 408
ZA - Sudafrica 386
NL - Olanda 355
FR - Francia 319
AR - Argentina 166
IN - India 164
RU - Federazione Russa 155
BD - Bangladesh 131
IQ - Iraq 102
DE - Germania 94
EC - Ecuador 91
MX - Messico 84
CO - Colombia 74
GB - Regno Unito 74
PH - Filippine 54
PK - Pakistan 52
TR - Turchia 51
ID - Indonesia 49
VE - Venezuela 48
CA - Canada 46
UZ - Uzbekistan 42
PL - Polonia 38
AT - Austria 37
PY - Paraguay 37
MA - Marocco 36
JP - Giappone 33
SA - Arabia Saudita 33
MY - Malesia 30
KE - Kenya 29
SE - Svezia 28
IE - Irlanda 27
EG - Egitto 25
ES - Italia 25
PE - Perù 23
CL - Cile 22
TN - Tunisia 22
UA - Ucraina 21
DZ - Algeria 19
FI - Finlandia 19
UY - Uruguay 18
JO - Giordania 16
TH - Thailandia 15
CR - Costa Rica 14
ET - Etiopia 14
LT - Lituania 14
IR - Iran 13
TW - Taiwan 12
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
IL - Israele 11
BO - Bolivia 10
CH - Svizzera 10
JM - Giamaica 10
KZ - Kazakistan 10
LB - Libano 9
PS - Palestinian Territory 9
KR - Corea 8
NP - Nepal 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
GR - Grecia 7
HN - Honduras 7
HU - Ungheria 7
OM - Oman 7
QA - Qatar 7
RO - Romania 7
SN - Senegal 7
NI - Nicaragua 6
AL - Albania 5
AU - Australia 5
BA - Bosnia-Erzegovina 5
BE - Belgio 5
BH - Bahrain 5
CI - Costa d'Avorio 5
LY - Libia 5
PA - Panama 5
PT - Portogallo 5
RS - Serbia 5
AO - Angola 4
GA - Gabon 4
GE - Georgia 4
GH - Ghana 4
MN - Mongolia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
TL - Timor Orientale 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AQ - Antartide 2
Totale 15.891
Città #
Singapore 1.693
San Jose 1.022
Hong Kong 798
Ho Chi Minh City 428
Ashburn 348
Santa Clara 348
Dallas 342
Johannesburg 341
Boardman 316
Hanoi 303
Lauterbourg 285
Beijing 201
Los Angeles 127
São Paulo 121
Moscow 118
Milan 61
Buffalo 60
Columbus 59
Haiphong 49
Council Bluffs 48
Da Nang 45
New York 44
Baghdad 43
Rio de Janeiro 38
Tashkent 38
Hefei 36
Nuremberg 36
Belo Horizonte 34
Quito 33
Brooklyn 31
Biên Hòa 29
Mexico City 28
Warsaw 28
Brasília 27
Shanghai 27
Dublin 26
Hải Dương 26
Rome 25
Curitiba 24
Chennai 23
Guayaquil 23
Munich 23
Dhaka 22
Guangzhou 22
Medellín 22
Tokyo 21
Assago 20
Stockholm 20
Nairobi 19
Vienna 19
Caracas 18
Fortaleza 18
Frankfurt am Main 18
Kuala Lumpur 18
Amsterdam 17
Asunción 17
Can Tho 17
Manaus 17
Orem 17
Chicago 16
Istanbul 16
Phoenix 16
San Francisco 16
Thái Bình 16
Cape Town 15
Guarulhos 15
Montevideo 15
Atlanta 14
Bogotá 14
Campinas 14
Erbil 14
Montreal 14
Ninh Bình 14
Salvador 14
Secaucus 14
Addis Ababa 13
Boston 13
Buenos Aires 13
London 13
Porto Alegre 13
Amman 12
Casablanca 12
Lahore 12
Recife 12
Riyadh 12
Toronto 12
Chandler 11
Parma 11
Turin 11
Turku 11
Baku 10
Bắc Ninh 10
Florianópolis 10
Goiânia 10
Maceió 10
Shijiazhuang 10
Cairo 9
Ha Long 9
Hangzhou 9
Juiz de Fora 9
Totale 8.591
Nome #
Updated systematic literature review and meta-analysis to inform the Italian Society of Rheumatology Recommendations on the treatment of rheumatoid arthritis-associated interstitial lung disease 103
Interstitial lung disease in Sjögren's syndrome: a clinical review 92
PREVALENCE, INCIDENCE AND SURVIVAL IN INTERSTITIAL LUNG DISEASE SECONDARY TO PRIMARY SJOGREN'S SYNDROME. RESULTS FROM THE "EMERGE" LONGITUDINAL STUDY 87
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysis 87
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 83
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 81
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 81
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 81
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases 79
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset 76
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 74
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 73
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 73
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 72
RADIOLOGIC AND SEROLOGIC FEATURES IN PATIENTS WITH INTERSTITIAL LUNG DISEASE SECONDARYTO SJOGREN'S SYNDROME. COLLABORATIVE STUDY OF ISLAND (ITALIAN STUDY GROUP ON LUNG INVOLVEMENT IN RHEUMATIC DISEASES) AND GRISS (GRUPPO DI RICERCA ITALIANO SULLA SINDROME DI SJÖGREN) STUDY GROUP OF SIR (ITALIAN SOCIETY OF RHEUMATOLOGY) 72
A new chance to treat rheumatoid arthritis lung fibrosis? 71
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature 71
REAL-WORLD EFFECTIVENESS OF UPADACITINIB ACROSS DIFFERENT CLINICAL PHENOTYPES IN A LARGE ITALIAN PSA COHORT 71
Lung complications of Sjogren syndrome 71
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 70
PROGRESSIVE MICROVASCULAR ABNORMALITIES DETECTABLE OVERTIME BY NAILFOLD VIDEOCAPILLAROSCOPY IN LONG-COVID PATIENTS: A MULTICENTER ITALIAN INVESTIGATION 70
SEX-BASED DIFFERENCES IN 24-MONTH TREATMENT OUTCOMES WITH B/TS-DMARDS IN PSORIATIC ARTHRITIS: REAL-WORLD EVIDENCE AND PREDICTIVE MODELING FROM THE GRUPPO ITALIANO STUDIO EARLY ARTHRITIS (GISEA) MULTICENTER PROSPECTIVE REGISTRY 70
Clinical and Serological Characteristics of Sjogren's Disease-related Lymphocytic Interstitial Pneumonia: A Large Multicenter Study 70
Procedural pain management in the treatment of scleroderma digital ulcers 70
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 70
Anti-TNF Therapy Is Not Associated with an Increase in Neoplasias in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry 69
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 69
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 69
Anti-TNF Therapy Is Associated with an Increase in Serious Infections in Patients with Spondyloarthritis (SpA), Especially during the First 12 Monts of Treatment: Results from the GISEA Registry 67
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 67
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 67
A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease 66
Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome 66
Aortic pulse wave velocity measurement in systemic sclerosis patients 66
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 66
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 66
Cardiac Involvement in Systemic Vasculitis 66
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 65
RADIOMICS AND MACHINE LEARNING FOR DIFFERENTIATING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS WITH USUAL INTERSTITIAL PNEUMONIA PATTERN 64
Guiding ILD management in systemic autoimmune rheumatic diseases 64
Rheumatoid arthritis related interstitial lung disease 64
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry 64
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 64
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 63
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 63
Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset 63
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 63
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 63
Acute exacerbation of interstitial lung disease associated with rheumatic disease 63
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients 63
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 62
Prevalenza delle epatiti nelle malattie reumatiche 62
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 62
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 62
Trattamento con Rituximab in pazienti con vasculite crioglobulinemica 61
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 61
Methotrexate and rheumatoid arthritis associated interstitial lung disease 61
AN OVERVIEW OF NAILFOLD CAPILLAROSCOPY IN ITALY: RESULTS FROM A NATIONAL SURVEY 61
Inibitori biologici del TNF alfa nella terapia dell’arterite di Takayasu 61
B-cells and mixed cryoglobulinemia 60
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 60
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard 59
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 59
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 59
Sindrome di Sjogren primitiva: descrizione clinica e sierologica di una casistica monocentrica 59
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists 59
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 59
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 58
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 58
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 58
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 58
Lung and Breast Cancer in Systemic Sclerosis: Correlations with the Disease's Features 58
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 58
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 58
Elevated Troponin Serum Levels in Adult Onset Still's Disease 58
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries 57
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study 57
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 57
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 57
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 57
Current treatment of hepatitis C-associated rheumatic diseases 57
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 57
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 56
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 56
Mixed cryoglobulinemia syndrome: where are we going to? 56
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 56
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib 56
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis from the CLASS project 56
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 56
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 55
Covid-19, a new possible mimicker of interstitial lung disease related to primary Sjögren’s syndrome: a case report 55
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study 55
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature 55
Storia naturale della sclerosi sistemica in Italia 55
AB1310 UTILIZATION AND ATTITUDES TOWARDS NAILFOLD VIDEOCAPILLAROSCOPY FOR THE ASSESSMENT OF MICROVASCULAR STATUS IN PATIENTS WITH LONG-COVID: A MULTICENTER ONLINE SURVEY 55
Hepatitis C virus and type 1 diabetes 54
Fibromyalgia and temporomandibular disorder: Comorbility or the same disease? 54
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 54
Pre-processing techniques to enhance the classification of lung sounds based on deep learning 54
Predicting Mortality in Patients with Rheumatoid Arthritis Related Interstitial Lung Disease: Expanding The GAP Model 54
Totale 6.430
Categoria #
all - tutte 61.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 1 0 0
2021/202215 0 0 0 0 4 0 1 2 0 0 1 7
2022/202343 6 2 2 3 2 7 0 3 15 2 1 0
2023/2024724 5 3 0 0 2 5 0 0 3 337 103 266
2024/20254.669 52 369 322 49 419 293 144 130 708 654 312 1.217
2025/202610.928 752 1.323 1.646 1.037 1.527 435 1.644 361 1.315 888 0 0
Totale 16.390